Literature DB >> 3582385

Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study.

P W Serruys, J W Deckers, H E Luijten, J H Reiber, J G Tijssen, D Chadha, P G Hugenholtz.   

Abstract

The vasodilatory action of molsidomine was studied by intracoronary injection of its active metabolite, Sin 1. In 10 patients repeat coronary angiography in multiple projections was performed before and 2 minutes after administration of 1 mg of Sin 1, and before and after a second injection 60 minutes later. Contours of obstructed and non-obstructed segments of the left coronary artery were quantitatively analysed with a computer-based angiography analysis system. Immediately after its administration, Sin 1 increased the mean diameters of 44 normal coronary segments by 12% (P less than 0.001). Significant vasodilation (8%) was still observed after 60 minutes. At that time, repeated administration of Sin 1 increased the vasodilation by an additional 14% with respect to the control situation. An increase in obstruction diameter was observed in 6 out of 8 obstructed segments. Mean increase in the minimal obstruction diameter was still 10% after 60 minutes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582385     DOI: 10.1093/oxfordjournals.eurheartj.a062268

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

Review 1.  The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review.

Authors:  A D'Ambrosio; G Patti; A Manzoli; G Sinagra; A Di Lenarda; F Silvestri; G Di Sciascio
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

Review 2.  How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?

Authors:  S Jost; C W Nolte; M Sturm; J Hausleiter; D Hausmann
Journal:  Int J Card Imaging       Date:  1998-12

Review 3.  [State of diagnostics and therapy of inflammatory cardiomyopathie].

Authors:  H P Schultheiss; U Kühl
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

Review 4.  Nonresponsiveness to antianginal therapy--a frequent problem?

Authors:  W Schulz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 5.  Immunosuppressive therapy in acute myocarditis: an 18 year systematic review.

Authors:  C P P Hia; W C L Yip; B C Tai; S C Quek
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

6.  Nitric Oxide-Based Treatment of Poor-Grade Patients After Severe Aneurysmal Subarachnoid Hemorrhage.

Authors:  Angelika Ehlert; Jitka Starekova; Gerd Manthei; Annette Ehlert-Gamm; Joachim Flack; Marie Gessert; Joachim Gerss; Volker Hesselmann
Journal:  Neurocrit Care       Date:  2020-06       Impact factor: 3.210

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.